• Publicationsclose
• Other research productsclose
• 2017-2021close
• Other ORP type close

ispartof: Crayfish News vol:43 issue:1-4 status: published

Anecdota - rare texts and images from early modern France https://anecdota.princeton.edu/archives/1802; Présentation et transcription de trois lettres autographes inédites de Pierre-Daniel Huet conservées à la New York Public Library

Overview of the activities of the Aviation Laboratory under German rule between 1940 and 1945. Although officially driven by scientific motivation only, the laboratory worked closely with German aviation research and contributed to the German war effort.

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the benefits and harms of intratympanic destructive interventions (aminoglycosides) for Ménière's disease.

Treatment of obstructive sleep apnoea (OSA) in adults is evolving, as new therapies have been explored and introduced in clinical practice, while other approaches have been refined or reconsidered. In this European Respiratory Society (ERS) guideline on non-continuous positive airway pressure (CPAP) therapies for OSA, we present recommendations determined by a systematic review of the literature. It is an update of the 2011 ERS statement on non-CPAP therapies, advanced into a clinical guideline. A multidisciplinary group of experts, including pulmonary, surgical, dentistry and ear-nose-throat specialists, methodologists and patient representatives considered the most relevant clinical questions (for both clinicians and patients) relating to the management of OSA. Eight key clinical questions were generated and a systematic review was conducted to identify published randomised clinical trials that answered these questions. We used the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach to assess the quality of the evidence and the strength of recommendations. The resulting guideline addresses gastric bypass surgery, custom-made dual-block mandibular advancement devices, hypoglossal nerve stimulation, myofunctional therapy, maxillo-mandibular osteotomy, carbonic anhydrase inhibitors and positional therapy. These recommendations can be used to benchmark quality of care for people with OSA across Europe and to improve outcomes.

Objectif : Décrire l’ensemble des interventions effectuées par les pharmaciens à la validation des ordonnances de l’Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval pour les usagers inscrits ou admis au regard des services pharmaceutiques et de l’offre de soins pharmaceutiques à la validation des ordonnances en vigueur. Méthode : Étude prospective recensant les interventions verbales et écrites des pharmaciens à la validation des ordonnances en présence d’une offre de soins pharmaceutiques pour une période de 21 jours. La collecte des données a été réalisée à partir du dossier pharmacologique informatisé et d’un outil de collecte standardisé. Résultats : Un total de 1651 interventions à la validation des ordonnances a été réalisé, dont 1076 verbales et 575 écrites. Les interventions les plus fréquentes sont en lien avec des avis pharmaceutiques (26,3 %), les ordonnances d’admission (12 %), les doses de médicament (11,3 %) et les moments d’administration (10,7 %). Parmi ces interventions, 53,2 % (n = 878) ont fait l’objet d’une documentation au dossier pharmacologique ou au dossier médical de l’usager, et 339 (20,5 %) découlent de l’offre de soins pharmaceutiques. Les activités réservées de la Loi 41 ont représenté 206 interventions (12,5 %). Conclusion : Plusieurs types d’interventions sont réalisées par les pharmaciens à la validation des ordonnances de notre établissement. Cette étude dresse un portrait des interventions selon un modèle de priorisation des usagers. Objective: To describe all the prescription validation interventions performed by Institut de cardiologie et de pneumologie de Québec – Université Laval pharmacists for both registered and admitted patients in link with pharmaceutical services and the current offer of pharmaceutical care for prescription validation. Method: A prospective study identifying the pharmacists’ verbal and written prescription validation interventions in the presence of an offer of pharmaceutical care for a 21-day period. Data were collected from computerized medication profiles and with the use of a standardized data collection tool. Results: A total of 1651 prescription validation interventions were performed, 1076 of which were verbal and 575 written. The most frequent interventions concerned pharmaceutical opinions (26.3%), admission prescriptions (12%), medication doses (11.3%), and administration times (10.7%). Of these interventions, 53.2% (n = 878) were recorded in the patient’s medication profile or medical record, and 339 (20.5%) stemmed from the offer of pharmaceutical care. The reserved activities for Bill 41 accounted for 206 interventions (12.5%). Conclusion: Several types of prescription validation interventions are performed by the pharmacists at our facility. This study provides an overview of the interventions according to a patient prioritization model.